Ultrasound Axillary Vein Access: Evaluation of Learning Curve for an Alternative Approach to Cardiac Device Implantation

Sponsor
University of Kansas Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT04382430
Collaborator
(none)
100
1
2
12.3
8.1

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the learning curve associated with Ultrasound (US) guided axillary vein access for cardiac device implantation based on length of procedure among operators of various levels of experience and to assess the 30-day complication rate for patients undergoing US guided device placement versus traditional implant methods.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ultrasound guided venous access
  • Procedure: Conventional technique
N/A

Detailed Description

Ultrasound (US) guided axillary vein access for device implantation is an uncommon approach to gain venous access for cardiac device implantation - an extremely common procedure. However, there has been a growing trend of utilizing this approach to obtain venous access for device implantation among operators. Axillary vein access was described back as far as 1997, when it was utilized for contrast guided venipuncture to access the axillary vein for device implantation. Literature has suggested that an axillary venous approach, with either a superficial landmark or radiographic contrast, has better long-term efficacy and lower lead complications than a conventional subclavian approach for patients that had permanent pacemaker implantation. There are a variety of ways to access the axillary vein including contrast venography to help localization, "blind puncture" (utilizing fluoroscopy to identify anatomical landmarks), and US. More recently, operators have begun to utilize US guidance for axillary vein access. Esmaiel has described that US guidance for axillary vein access could potentially improve the success rate of venous access and limit complications. Others, albeit few, have reported US guided access for cardiac device implantation has the ability to reduce complications, is faster to complete, and easier to learn. According to the Agency for Healthcare Research and Quality in the United States, US guided central venous catheter placement is one of the 11 patient safety practices that have the strongest evidence supporting its use in improving patient outcomes. Evidence supports US guidance being standard of care in central venous catheter placement and using US for axillary access as helpful in cardiac device implantation, but providers still utilize predominantly alternative approaches to obtain venous access via the subclavian vein, cephalic cutdown, extrathoracic axillary using fluoroscopy and thoracic axillary using fluoroscopy.

Currently, there is limited data describing outcomes, the efficiency of US guided axillary access for cardiac device implantation, and the learning curve associated with this technique. Data suggests that utilizing the US approach can improve outcomes, be more efficient, and be easier to learn. Investigators recently reported a high success (95%) and low complication rate with US guided axillary access in 187 patients. Despite this limited data, operators still largely use alternative approaches for venous access. In part, this may be due to the learning curve associated with US axillary venous access.

While there is data demonstrating the utility of US guided axillary access, there is little evidence showing the learning curve for operators associated with this technique. The aim of this project is to assess the learning curve of this technique among operators of various levels of experience.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The Study Group for this study will include 1 US experienced Electrophysiology (EP) attending, 4 US inexperienced EP attendings, and 1 US inexperienced EP fellow performing US cardiac device implantation (CDI). Each provider will perform 5 conventional CDI, 2 assisted US CDI to learn the procedure (except for experienced US attending), and 10 solo US CDI for a total of 17 procedures per provider (15 for experienced US attending). 100 patients will be needed for this study. This study will take approximately 16 weeks to complete.The Study Group for this study will include 1 US experienced Electrophysiology (EP) attending, 4 US inexperienced EP attendings, and 1 US inexperienced EP fellow performing US cardiac device implantation (CDI). Each provider will perform 5 conventional CDI, 2 assisted US CDI to learn the procedure (except for experienced US attending), and 10 solo US CDI for a total of 17 procedures per provider (15 for experienced US attending). 100 patients will be needed for this study. This study will take approximately 16 weeks to complete.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Ultrasound Axillary Vein Access: Evaluation of Learning Curve for an Alternative Approach to Cardiac Device Implantation
Actual Study Start Date :
May 28, 2020
Actual Primary Completion Date :
Jun 6, 2021
Actual Study Completion Date :
Jun 6, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: US Guided Axillary venous access

Physician/ provider will perform 2 unassisted & 10 solo Ultrasound (US) guided venous access and pocket creation cardiac device implant. First 2 device implant will be done to educate physicians about ultrasound guided venous access. Subsequent subject will be randomized to 2:1 in ultrasound vs. conventional technique.

Procedure: Ultrasound guided venous access
Each physician/ provider will perform 2 assisted ultrasound (US) guided venous access and pocket creation for cardiac device implant and 10 solo ultrasound guided cardiac device implant.

Active Comparator: Conventional technique

Physician/ provider will perform 5 cardiac device implant using conventional technique for venous access and pocket creation.

Procedure: Conventional technique
Physician will perform 5 cardiac device implant using conventional technique of venous access and pocket creation

Outcome Measures

Primary Outcome Measures

  1. Venous access time between US guided and conventional technique [During procedure]

    Assess changes in venous access and pocket creation time with progressive experience with US guided axillary venous access (learning curve).

  2. Time spent for pocket creation between US guided venous access technique and conventional technique. [During procedure]

    Compare the pocket creation time with US guided axillary venous access versus conventional techniques.

  3. Time spent to obtain venous access & pocket creation between experienced and inexperienced physicians. [During procedure]

    Compare venous access and pocket creation time amongst experienced and inexperienced physicians.

  4. To assess 30 day post procedure complications [30 Day post procedure]

    Assess 30-day complications between techniques.

  5. Assess acute procedural success between two techniques. [During procedure]

    Compare overall procedural success whether device was successfully placed or not post procedure between US guided axillary venous access & conventional technique. Success as Assigned- whether implant technique assigned was successful or whether had to switch to an alternative technique.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Sign written Informed Consent Form.

  • ≥18 years of age up to 90 years old.

  • Eligible and referred for cardiac device implantation.

  • BMI < 35.

Exclusion Criteria:
  • Unable to sign consent.

  • Patient eligible for cardiac device upgrades/ extractions, subcutaneous implantable cardioverter defibrillators (SICD) & leadless devices.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Kansas Medical Center Kansas City Kansas United States 66160

Sponsors and Collaborators

  • University of Kansas Medical Center

Investigators

  • Principal Investigator: Seth Sheldon, MD, University of Kansas Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Seth Sheldon, Clinical Assistant Professor of Medicine - Cardiology, Principal Investigator, University of Kansas Medical Center
ClinicalTrials.gov Identifier:
NCT04382430
Other Study ID Numbers:
  • STUDY00145717
First Posted:
May 11, 2020
Last Update Posted:
Oct 4, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Seth Sheldon, Clinical Assistant Professor of Medicine - Cardiology, Principal Investigator, University of Kansas Medical Center

Study Results

No Results Posted as of Oct 4, 2021